Hunan Er-Kang Pharmaceutical Co. Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 1,781.286 million compared to CNY 1,949.315 million a year ago. Operating income was CNY 201.385 million compared to CNY 192.454 million a year ago. Net income was CNY 181.395 million compared to CNY 165.063 million a year ago. Basic earnings per share from continuing operations was CNY 0.0882 compared to CNY 0.08 a year ago.